The Industrial Logic of Automated Nucleic Acid QC

Automated Capillary Electrophoresis for DNA and RNA Analysis

Automated capillary electrophoresis separates nucleic acid fragments by size with precision that manual gel methods cannot match. The Agilent Fragment Analyzer runs 12 to 96 samples in parallel, delivering sizing and quantification in under an hour. That speed and consistency is what makes it infrastructure, not just instrumentation.

In genomics and molecular biology, the system’s primary function is quality control for next-generation sequencing libraries, genomic DNA, PCR products, and RNA integrity. Labs handling cell-free DNA or high-throughput workflows depend on this layer of standardization to avoid costly sequencing failures downstream.

The operational friction it removes is the manual, low-throughput variability of gel electrophoresis. When a core facility or service lab runs hundreds of samples daily, automated fragment analysis becomes a prerequisite for throughput and reproducibility.

For procurement and supply chains, this type of instrument signals a lab’s maturity. It is not discretionary—it is a standard fixture in any facility that processes sequencing at scale. Agilent’s position in this space reflects a broader shift: the tools of molecular biology are becoming as automated and industrial as the assays they serve.

In China, the adoption of such systems tracks directly with the scaling of domestic sequencing capacity. As local genomics platforms expand, automated QC hardware becomes a hidden but necessary layer in the production pipeline.

Why it matters:
Automated capillary electrophoresis is the unsung workhorse of modern genomics. For labs scaling NGS throughput, the Fragment Analyzer eliminates a key manual bottleneck and imposes a standard of reproducibility that manual gels cannot provide.

View Product →